bacterin

Recon

Josh SandbergDecember 3, 2015
1,919

Xtant Medical finishes 3-D printer development for orthopedics: 4 key notes

By Laura Dyrda Xtant Medical’s subsidiary Bacterin developed a three-dimensional printer that can prototype custom, resorbable bone grafts for reconstructive procedures. Here…
Read More »
Josh SandbergAugust 26, 2015
1,175

Xtant Medical receives FDA clearance for demineralized bone matrix putty: 4 observations

By Anuja Vaidya Xtant Medical’s wholly owned subsidiary Bacterin has received FDA 510(k) clearance of its OsteoSelect PLUS Demineralized Bone Matrix Putty.…
Read More »
Biologics

Josh SandbergJuly 28, 2015
1,673

Bacterin to Purchase the Outstanding Common Stock of X-spine Systems, Inc., Creating Xtant Medical

Combines Bacterin’s strength in orthobiologics with X-spine’s expertise in hardware offering complementary product lines focused on orthopedic and spine surgical…
Read More »
Hospitals

Josh SandbergApril 6, 2015
1,810

Bacterin Announces OsteoSponge(R) Patent

BELGRADE, Mont., April 6, 2015 (GLOBE NEWSWIRE) — Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of…
Read More »
Biologics

Josh SandbergOctober 30, 2014
1,138

Bacterin Announces New Demineralized Bone Matrix Constructs for Spine Applications

BELGRADE, Mont., Oct. 29, 2014 (GLOBE NEWSWIRE) — Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of…
Read More »
Biologics

Josh SandbergOctober 16, 2014
1,241

Bacterin International Announces Sales Team Expansion

Bacterin Attracts Industry Top Sales Management Talent BELGRADE, Mont., Oct. 16, 2014 (GLOBE NEWSWIRE) — Bacterin announced today three senior…
Read More »
Biologics

Josh SandbergAugust 5, 2014
1,613

Bacterin Announces Clinical Results on the Use of OsteoSponge(R) SC Allograft Published in The Journal of Foot & Ankle Surgery

BELGRADE, Mont., Aug. 5, 2014 (GLOBE NEWSWIRE) — Bacterin International Holdings, Inc. (NYSE:BONE), a leader in the development of bone…
Read More »
Biologics

Josh SandbergJuly 1, 2014
768

Bacterin Announces the Appointment of Robert Di Silvio as President

BELGRADE, Mont., July 1, 2014 (GLOBE NEWSWIRE) — Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of…
Read More »
Josh SandbergAugust 1, 2011
707

Bacterin Secures $15 Million Credit Facility with MidCap Financial and Silicon Valley Bank

BELGRADE, Mont., Aug. 1, 2011 /PRNewswire via COMTEX/ — Bacterin International Holdings, Inc.BONE -3.78% , a leader in the development of…
Read More »
Josh SandbergMarch 7, 2011
696

Bacterin International Holdings, Inc. Receives Approval for Listing on NYSE Amex

BELGRADE, Mont., March 4, 2011 /PRNewswire via COMTEX/ — BELGRADE, Mont.,March 4, 2011 /PRNewswire/ — Bacterin International Holdings, Inc. (OTC Bulletin Board:…
Read More »
Josh SandbergMarch 1, 2011
872

Bacterin International Announces Major Orthopedic Hospital Group to Begin Use of OsteoSponge(R)SC

BELGRADE, Mont., Feb. 28, 2011 /PRNewswire via COMTEX/ — Bacterin International Holdings, Inc. (“Bacterin”) (OTC Bulletin Board: BIHI), a developer…
Read More »
Josh SandbergNovember 22, 2010
525

Bacterin International Secures Up To $9 Million of Potential $14 Million of Financing

BELGRADE, Mont., Nov. 22, 2010 /PRNewswire-FirstCall/ — Bacterin International Holdings, Inc. (OTC Bulletin Board: BIHI) (“Bacterin”), a creator and developer of revolutionary bone…
Read More »
Josh SandbergAugust 9, 2010
667

Bacterin Closes Private Placement With Total Raise of $9.2 Million

BELGRADE, Mont., Aug. 5 /PRNewswire-FirstCall/ — Bacterin International Holdings, Inc. (“Bacterin” or the “Company”) (OTC Bulletin Board: BIHI), a developer of anti-infective coatings…
Read More »
Josh SandbergJune 17, 2010
688

Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlane’s Network of Over 6,000 Medical Facilities

BELGRADE, Mont., June 16 /PRNewswire/ — Bacterin International, Inc., a developer of revolutionary bone graft material, today announced a three-year agreement to…
Read More »

bacterin

Xtant Medical finishes 3-D printer development for orthopedics: 4 key notes

Xtant Medical receives FDA clearance for demineralized bone matrix putty: 4 observations

Bacterin to Purchase the Outstanding Common Stock of X-spine Systems, Inc., Creating Xtant Medical

Bacterin Announces OsteoSponge(R) Patent

Bacterin Announces New Demineralized Bone Matrix Constructs for Spine Applications

Bacterin International Announces Sales Team Expansion

Bacterin Announces Clinical Results on the Use of OsteoSponge(R) SC Allograft Published in The Journal of Foot & Ankle Surgery

Bacterin Announces the Appointment of Robert Di Silvio as President

Bacterin Secures $15 Million Credit Facility with MidCap Financial and Silicon Valley Bank

Bacterin International Holdings, Inc. Receives Approval for Listing on NYSE Amex

Bacterin International Announces Major Orthopedic Hospital Group to Begin Use of OsteoSponge(R)SC

Bacterin International Secures Up To $9 Million of Potential $14 Million of Financing

Bacterin Closes Private Placement With Total Raise of $9.2 Million

Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlane’s Network of Over 6,000 Medical Facilities

New Study from HSS Reveals Minimally Invasive Procedure Can Delay Arthritis in Select Patients with Hip Impingement

Four mega mergers helped increase M&A in Q1

Sports Medicine Market Global Forecast 2024-2030, Featuring Key Players Zimmer Biomet, Medtronic, Smith & Nephew, Stryker, Novartis, Johnson & Johnson, Conmed and Surgalign Holdings.